Old Mission Capital LLC Organon & Co. Transaction History

Old Mission Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $652,053 - $934,256	-39,304 Reduced 77.33%	11,524 $200,000
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $979,455 - $1.25 Million	50,828 New	50,828 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $5,734 - $7,038	246 New	246 $6,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.93 Million - $2.49 Million	-63,242 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $1.81 Million - $2.35 Million	63,242 New	63,242 $1.93 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.